ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer
Turan Tufan, Jiekun Yang, Krishna Seshu Tummala, Harun Cingoz, Cem Kuscu, Sara J. Adair, Gamze Cömertpay, Sarbajeet Nagdas, Bernadette J. Goudreau, Husnu Umit Luleyap, Ku‐Lung Hsu, Dave F. Kashatus, Nabeel M. Bardeesy, Todd W. Bauer, Mazhar Adli
This study identifies ISL2 as an epigenetically silenced tumor suppressor in pancreatic cancer that regulates metabolism and presents therapeutic vulnerabilities.
bioRxiv · May 23, 2020 · PreprintMolecular Biology